A CHOC neuroscientist has developed a breakthrough method of DBS to treat secondary dystonia in pediatric patients.
Rapid Whole Genome Sequencing continues to provide answers and hope for parents of critically ill children with rare diseases
CHOC has ordered cutting-edge tests of rapid whole-genome sequencing (rWGS) on 150 patients, with 76 of them getting a precise diagnosis.
Landmark study of COVID-19 infection among K-12 students debunks early fears about transmission at schools
A CHOC and UC Irvine-led study of SARS-CoV-2 infection rates among the K-12 population concludes that within-school transmission is limited.
CHOC awarded $2.3-million grant to study how toxic stress and unpredictability in the early environment affects neurodevelopment
CHOC, in partnership with UC Irvine & Chapman University, received a grant to screen patients for adverse childhood experiences.
CHOC-UCI Pediatric Urology study illustrates how COVID-19 delayed emergency care
Patients delayed seeking treatment in the ER following the onset of symptoms of a testicular torsion during the beginning of the pandemic
CHOC leads first ED study on adverse childhood experiences and prevalence of food and housing insecurity
CHOC’s Emergency Department is leading a study on how food and housing insecurity impacts children’s health and environment.
